Evaluation of the effects of dexmedetomidine infusion on oxygenation and lung mechanics in morbidly obese patients with restrictive lung disease
Authors:
- Ahmed HasaninAHAhmed Hasanin
- Kareem TahaKTKareem Taha
- Bassant AbdelhamidBABassant Abdelhamid
- Ayman AbougabalAAAyman Abougabal
- Mohamed ElsayadMEMohamed Elsayad
- Amira RefaieARAmira Refaie
- Sarah AminSASarah Amin
- Shaimaa WahbaSWShaimaa Wahba
- Heba OmarHOHeba Omar
- Mohamed Maher KamelMKMohamed Maher Kamel
- Yaser AbdelwahabYAYaser Abdelwahab
- Shereen M. AminSAShereen M. Amin
Open Access
- 14 August 2018
- journal article
- research article
- Published by Springer Nature in BMC Anesthesiology
- Vol. 18 (1) , 1-8
Abstract
Dexmedetomidine infusion improves oxygenation and lung mechanics in patients with chronic obstructive lung disease; however, its effect in patients with restrictive lung disease has not been thoroughly investigated yet. The aim of this work was to evaluate the effects of dexmedetomidine infusion on oxygenation and lung mechanics in morbidly obese patients with restrictive lung disease. Forty-two morbidly obese patients scheduled for bariatric surgery were included in the study. Patients were randomized to receive either dexmedetomidine infusion at a bolus dose of 1mcg/Kg followed by infusion at 1 mcg/Kg/hour for 90 min (Dexmedetomidine group), or normal saline infusion (Control group). Both groups were compared with regard to: oxygenation {P/F ratio: PaO2/fraction of inspired oxygen (FiO2)}, lung compliance, dead space, plateau pressure, blood pressure, and heart rate. Dexmedetomidine group showed significant improvement of the PaO2/FiO2 ratio, and higher lung compliance compared to control group by the end of drug infusion. Dexmedetomidine group demonstrated decreased dead space, plateau pressure, blood pressure, and heart rate compared to control group by the end of drug infusion. A 90-min dexmedetomidine infusion resulted in moderate improvement in oxygenation and lung mechanics in morbidly obese patients with restrictive lung disease. clinicaltrials.gov : NCT02843698 on 20 July 2016.Keywords
Funding Information
- Cairo University
This publication has 21 references indexed in Scilit:
- The Effects of Short-Term Propofol and Dexmedetomidine on Lung Mechanics, Histology, and Biological Markers in Experimental ObesityAnesthesia & Analgesia, 2016
- Effects of dexmedetomidine on oxygenation and lung mechanics in patients with moderate chronic obstructive pulmonary disease undergoing lung cancer surgeryEuropean Journal of Anaesthesiology, 2016
- Best anaesthetic drug strategy for morbidly obese patientsCurrent Opinion in Anaesthesiology, 2016
- History of anaesthesiaEuropean Journal of Anaesthesiology, 2016
- Obesity: physiologic changes and implications for preoperative managementBMC Anesthesiology, 2015
- Perioperative lung protective ventilation in obese patientsBMC Anesthesiology, 2015
- Intravenous Infusion of Dexmedetomidine Combined Isoflurane Inhalation Reduces Oxidative Stress and Potentiates Hypoxia Pulmonary Vasoconstriction during One‐Lung Ventilation in PatientsMediators of Inflammation, 2015
- Recruitment of lung volume during surgery neither affects the postoperative spirometry nor the risk of hypoxaemia after laparoscopic gastric bypass in morbidly obese patients: a randomized controlled studyBritish Journal of Anaesthesia, 2014
- Effect of Intravenous Infusion of Dexmedetomidine Combined with Inhalation of Isoflurane on Arterial Oxygenation and Intrapulmonary Shunt During Single-Lung VentilationCell Biochemistry and Biophysics, 2013
- Effects of the α2-Adrenoceptor Agonist Dexmedetomidine on Bronchoconstriction in DogsAnesthesiology, 2004